[go: up one dir, main page]

ES2044206T3 - Procedimiento para la obtencion de un sistema terapeutico transdermal en forma de un emplasto con varias capas. - Google Patents

Procedimiento para la obtencion de un sistema terapeutico transdermal en forma de un emplasto con varias capas.

Info

Publication number
ES2044206T3
ES2044206T3 ES89810285T ES89810285T ES2044206T3 ES 2044206 T3 ES2044206 T3 ES 2044206T3 ES 89810285 T ES89810285 T ES 89810285T ES 89810285 T ES89810285 T ES 89810285T ES 2044206 T3 ES2044206 T3 ES 2044206T3
Authority
ES
Spain
Prior art keywords
transdermal therapeutic
therapeutic system
plaster
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89810285T
Other languages
English (en)
Inventor
Joel Dr Sinnreich
Peter Dr Fankhauser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2044206T3 publication Critical patent/ES2044206T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PATENTE AFECTA A UN SISTEMA TRANSDERMAL TERAPEUTICO EN FORMA DE EMPLASTO PARA LA ADMINISTRACION DE SUSTANCIAS ACTIVAS PERMEABLES, EN ESPECIAL DE FORMOTEROL, EN FORMA DE UN SISTEMA MATRICIAL COMPUESTO DE AL MENOS TRES CAPAS: A) UNA CAPA-CUBIERTA QUE NO DEJE PASAR LOS COMPONENTES DE LA CAPA ADHESIVA B); B) UNA CAPA ADHESIVA CAPAZ DE DEJAR PASAR LAS SUSTANCIAS ACTIVAS, HECHA DE UN MATERIAL POLIMERO, PERMEABLE, INOFENSIVO PARA LA PIEL, LA CUAL CONTIENE AL MENOS UNA SUSTANCIA ACTIVA PERMEABLE, UNA COMBINACION DE EUCALIPTOL CON UN GRADO DE PUREZA DE AL MENOS 70% Y UN MEDIO ADICIONAL DE PENETRACION CUTANEA Y, EN SU CASO, OTROS ADYUVANTES FARMACEUTICOS, Y C) UNA LAMINA PROTECTORA SEPARABLE DE LA CAPA ADHESIVA B).
ES89810285T 1988-04-22 1989-04-13 Procedimiento para la obtencion de un sistema terapeutico transdermal en forma de un emplasto con varias capas. Expired - Lifetime ES2044206T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH152488 1988-04-22

Publications (1)

Publication Number Publication Date
ES2044206T3 true ES2044206T3 (es) 1994-01-01

Family

ID=4212460

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89810285T Expired - Lifetime ES2044206T3 (es) 1988-04-22 1989-04-13 Procedimiento para la obtencion de un sistema terapeutico transdermal en forma de un emplasto con varias capas.

Country Status (16)

Country Link
US (1) US5079008A (es)
EP (1) EP0341202B1 (es)
JP (1) JPH01311017A (es)
KR (1) KR900015761A (es)
AT (1) ATE78704T1 (es)
AU (1) AU622162B2 (es)
DE (1) DE58901919D1 (es)
DK (1) DK193389A (es)
ES (1) ES2044206T3 (es)
GR (1) GR3005902T3 (es)
IE (1) IE60109B1 (es)
IL (1) IL89940A0 (es)
NZ (1) NZ228826A (es)
PH (1) PH27001A (es)
PT (1) PT90322B (es)
ZA (1) ZA892899B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0356382B1 (de) * 1988-08-02 1994-02-16 Ciba-Geigy Ag Mehrschichtiges Pflaster
CA2064845A1 (en) * 1989-08-17 1991-02-18 Sharad K. Govil Transdermal nitroglycerin patch with penetration enhancers
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
AU633733B2 (en) * 1990-05-17 1993-02-04 Hisamitsu Pharmaceutical Co., Inc. Percutaneous preparation containing estradiol
US5434304A (en) * 1990-09-26 1995-07-18 Aktiebolaget Astra Process for preparing formoterol and related compounds
EP0559825B1 (en) * 1990-11-28 1997-08-06 Sano Corporation Device for treating tobacco addiction
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
IT1251469B (it) * 1991-07-15 1995-05-15 Zambon Spa Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante.
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
US5827245A (en) * 1992-07-16 1998-10-27 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous)
US5807571A (en) * 1993-05-06 1998-09-15 Lts Lohmann Therapie-Systeme Gmbh Transdermal therapeutic systems for administering indole serotonin agonists
US5380760A (en) * 1993-11-19 1995-01-10 Minnesota Mining And Manufacturing Company Transdermal prostaglandin composition
JPH0827003A (ja) * 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
US5667799A (en) * 1995-10-30 1997-09-16 Caldwell; Larry J. Method for treating headache pain with topical local anesthetic compositions
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
WO1998014184A1 (fr) * 1996-10-04 1998-04-09 Saitama Daiichi Seiyaku Kabushiki Kaisha Timbre percutane
ATE293960T1 (de) * 1997-02-28 2005-05-15 Minnesota Mining & Mfg Transdermale vorrichtung zur verabreichungvon von testosteron
US5939477A (en) * 1998-02-02 1999-08-17 Dow Corning Corporation Silicone pressure sensitive adhesive composition containing functionalized polyisobutylene
US6103771A (en) * 1998-03-20 2000-08-15 Caldwell Galer Incorporated Method of treating neuroma pain
DE19908787A1 (de) * 1999-03-01 2000-09-14 Labtec Gmbh Transdermale Applikation von ß2-Sympathomimetika zur Behandlung obstruktiver Atemwegserkrankungen
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
DE19923427A1 (de) * 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
DE10001096A1 (de) * 2000-01-13 2001-07-26 Lohmann Therapie Syst Lts TTS mit Reservoirschicht zur Aufnahme und Abgabe von Duftstoffen
DE10056010A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Pflaster mit hautpflegenden Substanzen
DE10056011A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Hautfreundliches Wirkstoffpflaster zur insbesondere transdermalen Verabreichung ätherischer Öle
KR100469995B1 (ko) * 2002-05-20 2005-02-05 안국약품 주식회사 천식치료제를 함유한 매트릭스형 패취
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
WO2006047362A2 (en) 2004-10-21 2006-05-04 Durect Corporation Transdermal delivery systems
US20090098191A1 (en) * 2007-10-16 2009-04-16 Anderson Christopher G Use of bases to stabilize transdermal formulations
JP4934163B2 (ja) * 2009-03-18 2012-05-16 オカモト株式会社 皮膚貼付積層体
CN102597149A (zh) * 2009-07-21 2012-07-18 迈兰公司 用于连续制造聚异丁烯基透皮贴剂的工艺
CN102160857A (zh) * 2010-02-24 2011-08-24 日东电工株式会社 哌甲酯贴剂
FR2992325B1 (fr) 2012-06-26 2015-05-22 Ab7 Innovation Matrice sequencee multifonctionnelle monopolymerique en polyurethane coule et procede de fabrication
US9962340B2 (en) 2015-06-09 2018-05-08 Life Tech Global, Llc Device and method for the transdermal delivery of cannabidiol
US10272125B2 (en) * 2015-09-14 2019-04-30 Life Tech Global, Llc Transdermal delivery of cannabidiol with other active moieties including cannabinoids

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440770A (en) * 1980-07-28 1984-04-03 Mochida Seiyaku Kabushiki Kaisha Diuretic, hypotensive and antiedemic quinoline oximes
US4440777A (en) * 1981-07-07 1984-04-03 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
US4560553A (en) * 1981-07-07 1985-12-24 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
DE3344691A1 (de) * 1983-12-10 1985-06-20 Bayer Ag, 5090 Leverkusen Wirkstoffabgasesysteme
GR81250B (en) * 1983-12-22 1985-11-19 American Home Prod Menthol enhancement of transdermal drug delivery
DE3347278A1 (de) * 1983-12-28 1985-07-11 Bayer Ag, 5090 Leverkusen Wirkstoffabgabesysteme
JPS60174716A (ja) * 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤
DE3423328A1 (de) * 1984-06-23 1986-01-02 Beiersdorf Ag, 2000 Hamburg Selbstklebendes pflaster
DE3564073D1 (en) * 1984-06-23 1988-09-08 Beiersdorf Ag Self-adhesive plaster
ATE95430T1 (de) * 1984-12-22 1993-10-15 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster.
DE3518707A1 (de) * 1985-05-24 1986-11-27 Beiersdorf Ag, 2000 Hamburg Nitro-pflaster
EP0204968B1 (de) * 1985-05-24 1989-09-27 Beiersdorf Aktiengesellschaft Nitro-Pflaster
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
US4943435A (en) * 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch

Also Published As

Publication number Publication date
DK193389A (da) 1989-10-23
IL89940A0 (en) 1989-12-15
NZ228826A (en) 1990-10-26
EP0341202B1 (de) 1992-07-29
KR900015761A (ko) 1990-11-10
DE58901919D1 (en) 1992-09-03
PT90322A (pt) 1989-11-10
ZA892899B (en) 1989-12-27
IE60109B1 (en) 1994-06-01
US5079008A (en) 1992-01-07
AU3268689A (en) 1989-10-26
JPH01311017A (ja) 1989-12-15
GR3005902T3 (es) 1993-06-07
PH27001A (en) 1993-02-01
DK193389D0 (da) 1989-04-20
IE891295L (en) 1989-10-22
AU622162B2 (en) 1992-04-02
EP0341202A1 (de) 1989-11-08
ATE78704T1 (de) 1992-08-15
PT90322B (pt) 1994-11-30

Similar Documents

Publication Publication Date Title
ES2044206T3 (es) Procedimiento para la obtencion de un sistema terapeutico transdermal en forma de un emplasto con varias capas.
US4573996A (en) Device for the administration of an active agent to the skin or mucosa
HK1003322A1 (en) Device for administering an active agent to the skin or mucosa
ES2035928T3 (es) Dispositivo para administrar un agente activo a la piel o a la mucosa.
IE892488L (en) Multilayer plaster
JP4388068B2 (ja) 活性剤移動バリア層を含む経皮パッチ
MX9603667A (es) Dispositivo de suministro transdermico compuesto adhesivo que contiene droga.
MY109926A (en) Transdermal therapeutic system comprising galanthamine as active component
PT81751B (pt) Processo para a preparacao de adesivos para aplicacao de medicamentos por via transdermica
NO951523D0 (no) Plaster for transdermal administrering av flyktige, farmasöytisk aktive, kjemisk basiske bestanddeler, samt fremgangsmåte for fremstilling av plasteret
US6086912A (en) Topical drug delivery system
KR900013993A (ko) 활성물질의 국소 또는 계통적 투여를 위한 단계적 약물 방출을 나타내는 경피 시스템 및 그 용도
HUT77085A (hu) Ösztradioltartalmú transzdermális terápiás rendszer TTS vízmegkötő adalékokkal és eljárás előállítására
PT944384E (pt) Sistema para administracao transdermica de farmacos para o tratamento de doencas do coracao

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 341202

Country of ref document: ES